Example: stock market

DRUGS TO AVOID IN G6PD DEFICIENCY

DRUGS TO AVOID IN G6PD DEFICIENCYDEFINITE RISK OF HAEMOLYSISPOSSIBLE RISK OF HAEMOLYSISP harmacologicalClassDrugs*Pharmacological ClassDrugs* -Naphthol Niridazole Stibophen Nitrofurans- Nitrofurantoin- Nitrofurazone Quinolones- Ciprofloxacin- Moxifloxacin- Nalidixic acid- Norfloxacin- Ofloxacin Chloramphenicol Sulfonamides- Co-trimoxazole(Sulfamethoxazole +Trimethoprim)- Sulfacetamide- Sulfadiazine- Sulfadimidine- Sulfamethoxazole- Sulfanilamide- Sulfapyridine- Sulfasalazine(Salazosulfapyridine)- Sulfisoxazole(Sulfafurazole) Mepacrine Pamaquine Pentaquine Primaquine Methylene blue Dapsone Para-aminosalicylic acid Sulfones- Aldesulfone sodium (Sulfoxone)- Glucosulfone- Thiazosulfone Doxorubicin Rasburicase Phenazopyridine(Pyridium) Acetylphenylhydrazine Phenylhydrazine Acetylsalicylic acid(Aspirin) Acetanilide Paracetamol(Acetaminophen) Aminophenazone(Aminopyrine) Dipyrone(Metamizole) Phenacetin Phenazone(Antipyrine) Phenylbutazone Tiaprofenic acid Furazolidone Streptomycin Sulfonamides- Sulfacytine- Sulfaguanidine- Sulfamerazine- Sulfamethoxypyridazole Phenytoin Glibenclamide Dimercaprol (BAL) Antazoline

DRUGS TO AVOID IN G6PD DEFICIENCY DEFINITE RISK OF HAEMOLYSIS POSSIBLE RISK OF HAEMOLYSIS Pharmacological Class Drugs* Pharmacological Class Drugs* • ß-Naphthol

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Transcription of DRUGS TO AVOID IN G6PD DEFICIENCY

1 DRUGS TO AVOID IN G6PD DEFICIENCYDEFINITE RISK OF HAEMOLYSISPOSSIBLE RISK OF HAEMOLYSISP harmacologicalClassDrugs*Pharmacological ClassDrugs* -Naphthol Niridazole Stibophen Nitrofurans- Nitrofurantoin- Nitrofurazone Quinolones- Ciprofloxacin- Moxifloxacin- Nalidixic acid- Norfloxacin- Ofloxacin Chloramphenicol Sulfonamides- Co-trimoxazole(Sulfamethoxazole +Trimethoprim)- Sulfacetamide- Sulfadiazine- Sulfadimidine- Sulfamethoxazole- Sulfanilamide- Sulfapyridine- Sulfasalazine(Salazosulfapyridine)- Sulfisoxazole(Sulfafurazole) Mepacrine Pamaquine Pentaquine Primaquine Methylene blue Dapsone Para-aminosalicylic acid Sulfones- Aldesulfone sodium (Sulfoxone)- Glucosulfone- Thiazosulfone Doxorubicin Rasburicase Phenazopyridine(Pyridium) Acetylphenylhydrazine Phenylhydrazine Acetylsalicylic acid(Aspirin) Acetanilide Paracetamol(Acetaminophen) Aminophenazone(Aminopyrine) Dipyrone(Metamizole) Phenacetin Phenazone(Antipyrine) Phenylbutazone Tiaprofenic acid Furazolidone Streptomycin Sulfonamides- Sulfacytine- Sulfaguanidine- Sulfamerazine- Sulfamethoxypyridazole Phenytoin Glibenclamide Dimercaprol (BAL) Antazoline (Antistine) Diphenhydramine Tripelennamine Hydralazine Methyldopa Chloroquine & derivatives Proguanil Pyrimethamine Quinidine Quinine Isoniazid Trihexyphenidyl(Benzhexol) Dopamine (L-dopa)

2 Procainamide Quinidine Toluidine blue Colchicine Probenecid Mestranol Isobutyl nitrite Menadiol Na sulfate Menadione Menadione Na bisulfite Phytomenadione Ascorbic acid (Vit C) (rare) Arsine Berberine(in Coptis chinensis) Fava beans Naphthalene(in mothballs) Para-aminobenzoic acidAnthelminticsAntibioticsAntimalarial sAntimethemo-globinaemic AgentsAntimycobacterialsAntineoplastic AdjunctsGenitourinary AnalgesicsOthersAnalgesicsAntibioticsAnt iconvulsantsAntidiabeticsAntidotesAntihi staminesAntihypertensivesAntimalarialsAn timycobacterialsAntiparkinsonism AgentsCardiovascular DrugsDiagnostic Agentfor Cancer DetectionGout PreparationsHormonal ContraceptivesNitratesVitamin K SubstanceVitaminsOthersPlease refer to the Contents page for more Summary Summary TableG6PD Deficiencyver01032006*Nomenclature based on INN (International non-proprietary name)Refer to for further 2006 MIMS


Related search queries